Evidence map›Paper›PMID 29163349›Full record

ArticleFrontiers in neurology2017

Kainic Acid-Induced Post-Status Epilepticus Models of Temporal Lobe Epilepsy with Diverging Seizure Phenotype and Neuropathology.

Daniele Bertoglio, Halima Amhaoul, Annemie Van Eetveldt, Ruben Houbrechts, Sebastiaan Van De Vijver, Idrish Ali, Stefanie Dedeurwaerdere

Abstract read
In one paragraph

Article in Frontiers in neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Sudden Unexpected Death in Epilepsy: Central Respiratory Chemoreception.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Neuroprotective effects of trigonelline in kainic acid-induced epilepsy: Behavioral, biochemical, and functional insights.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Aqueous extract ofFrontiers in pharmacology · 2022
    Article
  18. Blood Neurofilament Light Chain as a Potential Biomarker for Central and Peripheral Nervous Toxicity in Rats.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Article
  19. What value can TSPO PET bring for epilepsy treatment?European journal of nuclear medicine and molecular imaging · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniele BertoglioDepartment of Translational Neurosciences, University of Antwerp, Antwerp, Belgium.
Halima AmhaoulDepartment of Translational Neurosciences, University of Antwerp, Antwerp, Belgium.
Annemie Van EetveldtDepartment of Translational Neurosciences, University of Antwerp, Antwerp, Belgium.
Ruben HoubrechtsDepartment of Translational Neurosciences, University of Antwerp, Antwerp, Belgium.
Sebastiaan Van De VijverDepartment of Translational Neurosciences, University of Antwerp, Antwerp, Belgium.
Idrish AliDepartment of Translational Neurosciences, University of Antwerp, Antwerp, Belgium.
Stefanie DedeurwaerdereDepartment of Translational Neurosciences, University of Antwerp, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of epilepsy models is to investigate disease ontogenesis and therapeutic interventions in a consistent and prospective manner. The kainic acid-induced

Indexed as

epilepsy modelepileptogenesisspontaneous recurrent seizuresstatus epilepticusstraintranslocator protein

Identifiers

PMID29163349
PMCPMC5681498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.